• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by P3 Health Partners Inc. (Amendment)

    6/12/23 8:21:19 AM ET
    $PIII
    Medical/Nursing Services
    Health Care
    Get the next $PIII alert in real time by email
    SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No.3 P3 HEALTH PARTNERS INC CLASS A COMMON STOCK Cusip #744413105 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #744413105 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 6,686,881 Item 6: 0 Item 7: 6,686,884 Item 8: 0 Item 9: 6,686,884 Item 11: 6.038% Item 12: HC Cusip #744413105 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 6,686,884 Item 8: 0 Item 9: 6,686,884 Item 11: 6.038% Item 12: IN Item 1(a). Name of Issuer: P3 HEALTH PARTNERS INC Item 1(b). Address of Issuer's Principal Executive Offices: 2045 W GRAND AVE, STE B PMB # 82152 CHICAGO, IL 60612-1577 USA Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: CLASS A COMMON STOCK Item 2(e). CUSIP Number: 744413105 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 6,686,884 (b) Percent of Class: 6.038% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 6,686,884 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the CLASS A COMMON STOCK of P3 HEALTH PARTNERS INC. No one other person's interest in the CLASS A COMMON STOCK of P3 HEALTH PARTNERS INC is more than five percent of the total outstanding CLASS A COMMON STOCK. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing orinfluencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. June 9, 2023 Date /s/ Stephanie J. Brown Signature Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification FIAM LLC IA Fidelity Management & Research Company LLC * IA Fidelity Management Trust Company BK * Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on June 9, 2023, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the CLASS A COMMON STOCK of P3 HEALTH PARTNERS INC at May 31, 2023. FMR LLC By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson** * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
    Get the next $PIII alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PIII

    DatePrice TargetRatingAnalyst
    4/1/2024Buy → Neutral
    BTIG Research
    9/1/2023$5.00Buy
    BTIG Research
    6/30/2023Market Perform
    TD Cowen
    1/4/2022Outperform
    William Blair
    More analyst ratings

    $PIII
    Leadership Updates

    Live Leadership Updates

    See more
    • P3 Health Partners Names Leif Pedersen New Chief Financial Officer

      P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, announced today that Leif Pedersen, an experienced finance, operational and value-based care executive, will join the company as chief financial officer (CFO) effective October 1, 2024. Pedersen succeeds Atul Kavthekar, who will continue as CFO until September 30, 2024, after which he will serve as a Strategic Advisor to the company. Pedersen was most recently Vice President of Finance & CFO Shared Services for Optum Health, a division of UnitedHealth Group. Prior to Optum Health, Pedersen served as Vice President of Finance & CFO IT at DaVita Medical Group. He brings m

      8/29/24 4:05:00 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • P3 Health Partners Names Dr. Aric Coffman as CEO

      P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), today named Dr. Aric Coffman as P3's Chief Executive Officer, effective as of May 8, 2024, succeeding Dr. Sherif Abdou, P3's Co-Founder. Dr. Abdou will continue to serve as a Strategic Advisor to P3, and a member of the Company's Board of Directors working closely with Dr. Coffman to ensure a smooth transition. Dr. Coffman is an exceptional physician leader with a proven track record of success in the value-based care sector, most recently as the CEO of Honest Medical Group, a Rubicon Founders portfolio company. He brings over two decades of experience in leading provider organizations in delivering high quality, highly effici

      5/8/24 4:05:00 PM ET
      $PIII
      Medical/Nursing Services
      Health Care

    $PIII
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • P3 Health Partners Schedules First Quarter 2025 Earnings Release and Conference Call

      P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for first quarter 2025 and file its Quarterly Report on Form 10-Q on Thursday, May 15, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health First Quarter Earnings Conference Call Date & Time May 15, 2025, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 Ask to be joined into the P3 Health Partners call

      5/8/25 4:05:00 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • P3 Health Partners to Participate in the 24th Annual Needham Virtual Healthcare Conference

      P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming 24th Annual Needham Virtual Healthcare Conference. Management will give a presentation on Thursday, April 10, 2025, at 9:45 AM Pacific Time. A webcast of the presentation will be available on P3's Investor Relations Website at https://ir.p3hp.org/. A replay will be available on P3's investor relations webpage for 30 days following the presentation. About P3 Health Partners (NASDAQ:PIII): P3 Health Partners Inc. is a leading population health management company committed to transforming healthcare by improving the

      4/2/25 8:05:00 AM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results

      Revenue increased 18% year-over-year to $1.50 billion Affirming 2025 guidance Management to Host Conference Call and Webcast [March 27, 2025] at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient- centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2024, and affirmed its 2025 guidance. "Our business model remains fundamentally strong as we continue to deliver member and top-line growth, quality outcomes, and provider retention," said Aric Coffman, CEO of P3. "With the $130M+ in identified programmatic opportunities advancing our path to financial su

      3/27/25 4:22:00 PM ET
      $PIII
      Medical/Nursing Services
      Health Care

    $PIII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Large owner Chicago Pacific Founders Ugp Iii, Llc

      4 - P3 Health Partners Inc. (0001832511) (Issuer)

      1/31/25 7:05:33 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • SEC Form 3 filed by new insider Pedersen Leif Elliott

      3 - P3 Health Partners Inc. (0001832511) (Issuer)

      10/1/24 5:35:14 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • Large owner Chicago Pacific Founders Ugp Iii, Llc bought $81,552 worth of shares (160,000 units at $0.51) (SEC Form 4)

      4 - P3 Health Partners Inc. (0001832511) (Issuer)

      9/13/24 9:56:09 PM ET
      $PIII
      Medical/Nursing Services
      Health Care

    $PIII
    Financials

    Live finance-specific insights

    See more
    • P3 Health Partners Schedules First Quarter 2025 Earnings Release and Conference Call

      P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for first quarter 2025 and file its Quarterly Report on Form 10-Q on Thursday, May 15, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health First Quarter Earnings Conference Call Date & Time May 15, 2025, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 Ask to be joined into the P3 Health Partners call

      5/8/25 4:05:00 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results

      Revenue increased 18% year-over-year to $1.50 billion Affirming 2025 guidance Management to Host Conference Call and Webcast [March 27, 2025] at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient- centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2024, and affirmed its 2025 guidance. "Our business model remains fundamentally strong as we continue to deliver member and top-line growth, quality outcomes, and provider retention," said Aric Coffman, CEO of P3. "With the $130M+ in identified programmatic opportunities advancing our path to financial su

      3/27/25 4:22:00 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • P3 Health Partners to Report Fourth Quarter and Full Year 2024 Financial Results on March 27

      P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for the fourth quarter and full year 2024 on March 27, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health Fourth Quarter Earnings Conference Call Date & Time March 27, 2025, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 Ask to be joined into the P3 Health Partners call   The conference call will

      3/13/25 4:05:00 PM ET
      $PIII
      Medical/Nursing Services
      Health Care

    $PIII
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • P3 Health Partners downgraded by BTIG Research

      BTIG Research downgraded P3 Health Partners from Buy to Neutral

      4/1/24 7:39:12 AM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • BTIG Research initiated coverage on P3 Health Partners with a new price target

      BTIG Research initiated coverage of P3 Health Partners with a rating of Buy and set a new price target of $5.00

      9/1/23 7:31:24 AM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • TD Cowen initiated coverage on P3 Health Partners

      TD Cowen initiated coverage of P3 Health Partners with a rating of Market Perform

      6/30/23 7:34:42 AM ET
      $PIII
      Medical/Nursing Services
      Health Care

    $PIII
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by P3 Health Partners Inc.

      SC 13G - P3 Health Partners Inc. (0001832511) (Subject)

      11/14/24 4:33:46 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13D/A filed by P3 Health Partners Inc.

      SC 13D/A - P3 Health Partners Inc. (0001832511) (Subject)

      11/8/24 5:15:05 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13D/A filed by P3 Health Partners Inc.

      SC 13D/A - P3 Health Partners Inc. (0001832511) (Subject)

      6/26/24 4:30:49 PM ET
      $PIII
      Medical/Nursing Services
      Health Care

    $PIII
    SEC Filings

    See more
    • SEC Form DEF 14A filed by P3 Health Partners Inc.

      DEF 14A - P3 Health Partners Inc. (0001832511) (Filer)

      4/29/25 4:27:49 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • SEC Form PRE 14A filed by P3 Health Partners Inc.

      PRE 14A - P3 Health Partners Inc. (0001832511) (Filer)

      4/18/25 5:28:07 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • P3 Health Partners Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

      8-K - P3 Health Partners Inc. (0001832511) (Filer)

      4/16/25 8:09:19 PM ET
      $PIII
      Medical/Nursing Services
      Health Care

    $PIII
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Chicago Pacific Founders Ugp Iii, Llc bought $81,552 worth of shares (160,000 units at $0.51) (SEC Form 4)

      4 - P3 Health Partners Inc. (0001832511) (Issuer)

      9/13/24 9:56:09 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • Large owner Chicago Pacific Founders Ugp Iii, Llc bought $128,624 worth of shares (240,000 units at $0.54) (SEC Form 4)

      4 - P3 Health Partners Inc. (0001832511) (Issuer)

      9/12/24 8:12:24 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • Large owner Chicago Pacific Founders Ugp Iii, Llc bought $117,544 worth of shares (240,000 units at $0.49) (SEC Form 4)

      4 - P3 Health Partners Inc. (0001832511) (Issuer)

      9/11/24 6:17:20 AM ET
      $PIII
      Medical/Nursing Services
      Health Care